Curcumin analogues and their hybrid molecules as multifunctional drugs.

[1]  F. C. Rodrigues,et al.  Developments in the anticancer activity of structurally modified curcumin: An up-to-date review. , 2019, European journal of medicinal chemistry.

[2]  G. Liang,et al.  Design and synthesis novel di-carbonyl analogs of curcumin (DACs) act as potent anti-inflammatory agents against LPS-induced acute lung injury (ALI). , 2019, European journal of medicinal chemistry.

[3]  J. Sangshetti,et al.  Synthesis and evaluation of pyrazole‐incorporated monocarbonyl curcumin analogues as antiproliferative and antioxidant agents , 2019, Journal of the Chinese Chemical Society.

[4]  S. Atkin,et al.  Current evidence and future perspectives for curcumin and its analogues as promising adjuncts to oxaliplatin: state‐of‐the‐art , 2019, Pharmacological research.

[5]  Mhd Anas Tomeh,et al.  A Review of Curcumin and Its Derivatives as Anticancer Agents , 2019, International journal of molecular sciences.

[6]  B. Salehi,et al.  The therapeutic potential of curcumin: A review of clinical trials. , 2019, European journal of medicinal chemistry.

[7]  Wei Zhao,et al.  Hydroxyl-substituted double Schiff-base condensed 4-piperidone/cyclohexanones as potential anticancer agents with biological evaluation , 2019, Journal of enzyme inhibition and medicinal chemistry.

[8]  S. Atkin,et al.  Evidence of curcumin and curcumin analogue effects in skin diseases: A narrative review , 2018, Journal of cellular physiology.

[9]  Hari Prasad Devkota,et al.  Curcumin, the golden spice in treating cardiovascular diseases. , 2019, Biotechnology advances.

[10]  H. Suleria,et al.  Cucurmin, anticancer, & antitumor perspectives: A comprehensive review , 2018, Critical reviews in food science and nutrition.

[11]  P. Álvarez,et al.  Latest in Vitro and in Vivo Assay, Clinical Trials and Patents in Cancer Treatment using Curcumin: A Literature Review , 2018, Nutrition and cancer.

[12]  Sujuan Wang,et al.  Synthesis of water-soluble curcumin derivatives and their inhibition on lysozyme amyloid fibrillation. , 2018, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[13]  C. Selvam,et al.  Synthesis, evaluation of cytotoxic properties of promising curcumin analogues and investigation of possible molecular mechanisms , 2018, Chemical biology & drug design.

[14]  H. Shibata,et al.  Synthetic Analogs of Curcumin Modulate the Function of Multidrug Resistance–Linked ATP-Binding Cassette Transporter ABCG2 , 2017, Drug Metabolism and Disposition.

[15]  M. Rosini,et al.  Curcumin in Alzheimer's disease: Can we think to new strategies and perspectives for this molecule? , 2017, Pharmacological research.

[16]  Shanchun Guo,et al.  Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies. , 2017, European journal of medicinal chemistry.

[17]  Z. Hussain,et al.  Synthesis and mechanistic studies of curcumin analog‐based oximes as potential anticancer agents , 2017, Chemical biology & drug design.

[18]  Shanshan Wang,et al.  Synthesis and biological evaluation of curcumin analogs as β-amyloid imaging agents. , 2017, Future medicinal chemistry.

[19]  F. Abas,et al.  Suppression of PGE2 production via disruption of MAPK phosphorylation by unsymmetrical dicarbonyl curcumin derivatives , 2017, Medicinal Chemistry Research.

[20]  Jun Du,et al.  Identification of 4‐arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase , 2017, Biochemical pharmacology.

[21]  H. Thu,et al.  Exploring recent developments to improve antioxidant, anti-inflammatory and antimicrobial efficacy of curcumin: A review of new trends and future perspectives. , 2017, Materials science & engineering. C, Materials for biological applications.

[22]  Bo Zhou,et al.  Design, synthesis, and evaluation of curcumin derivatives as Nrf2 activators and cytoprotectors against oxidative death. , 2017, European journal of medicinal chemistry.

[23]  C. Anwar,et al.  Synthesis of Curcumin Analogues Monoketone from Cinnamaldehyde and their Inhibition Assay against Alpha-Glucosidase Enzyme , 2017 .

[24]  H. Dai,et al.  Design, Synthesis and Bioactivities of Novel 1,4-Pentadien-3-one Derivatives Containing a Substituted Pyrazolyl Moiety , 2017, Molecules.

[25]  Shilong Zheng,et al.  Structure-activity relationship studies of 1,7-diheteroarylhepta-1,4,6-trien-3-ones with two different terminal rings in prostate epithelial cell models. , 2017, European journal of medicinal chemistry.

[26]  Jinhui Hu,et al.  Design, synthesis, and evaluation of multitarget-directed ligands against Alzheimer's disease based on the fusion of donepezil and curcumin. , 2017, Bioorganic & medicinal chemistry.

[27]  Fenfen Ma,et al.  Discovery of novel anti-tumor curcumin analogues from the optimization of curcumin scaffold , 2017, Medicinal Chemistry Research.

[28]  F. Devínsky,et al.  Synthesis, structural characterization and biological activity of novel Knoevenagel condensates on DLD-1 human colon carcinoma. , 2017, Bioorganic & medicinal chemistry letters.

[29]  Ahmad M. Alhajoj,et al.  Synthesis and Evaluation of Curcuminoid Analogues as Antioxidant and Antibacterial Agents , 2017, Molecules.

[30]  N. Jafari,et al.  Potent anti-cancer effects of less polar Curcumin analogues on gastric adenocarcinoma and esophageal squamous cell carcinoma cells , 2017, Scientific Reports.

[31]  Tibor Vellai,et al.  Mannich Curcuminoids as Potent Anticancer Agents , 2017, Archiv der Pharmazie.

[32]  Hang Xiao,et al.  Structure-Activity Relationship of Curcumin: Role of the Methoxy Group in Anti-inflammatory and Anticolitis Effects of Curcumin. , 2017, Journal of agricultural and food chemistry.

[33]  Hui-Yi Lin,et al.  New bis(hydroxymethyl) alkanoate curcuminoid derivatives exhibit activity against triple-negative breast cancer in vitro and in vivo. , 2017, European journal of medicinal chemistry.

[34]  L. Dardenne,et al.  Design, synthesis and evaluation of novel feruloyl-donepezil hybrids as potential multitarget drugs for the treatment of Alzheimer's disease. , 2017, European journal of medicinal chemistry.

[35]  X. Liu,et al.  Diarylpentadienone derivatives (curcumin analogues): Synthesis and anti-inflammatory activity. , 2017, Bioorganic & medicinal chemistry letters.

[36]  Li Chen,et al.  Design, synthesis and biological evaluation of multifunctional tacrine-curcumin hybrids as new cholinesterase inhibitors with metal ions-chelating and neuroprotective property. , 2017, Bioorganic & medicinal chemistry.

[37]  Feiyan Liu,et al.  Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy , 2017, Scientific Reports.

[38]  W. Ye,et al.  Structure- and isoform-specific glucuronidation of six curcumin analogs , 2017, Xenobiotica; the fate of foreign compounds in biological systems.

[39]  A. Nieto-Camacho,et al.  Synthesis of Curcuminoids and Evaluation of Their Cytotoxic and Antioxidant Properties , 2017, Molecules.

[40]  R. El-Shishtawy,et al.  Chemical modification of curcumin: Solubility and antioxidant capacity , 2017 .

[41]  N. Alitheen,et al.  Synthetic curcumin derivative DK1 possessed G2/M arrest and induced apoptosis through accumulation of intracellular ROS in MCF-7 breast cancer cells , 2017, Cancer Cell International.

[42]  Qing Xu,et al.  Synthesis, biological evaluation, QSAR and molecular dynamics simulation studies of potential fibroblast growth factor receptor 1 inhibitors for the treatment of gastric cancer. , 2017, European journal of medicinal chemistry.

[43]  V. Khedkar,et al.  Quinolidene based monocarbonyl curcumin analogues as promising antimycobacterial agents: Synthesis and molecular docking study. , 2017, Bioorganic & medicinal chemistry letters.

[44]  A. Kamal,et al.  Synthesis and biological evaluation of curcumin inspired indole analogues as tubulin polymerization inhibitors. , 2017, European journal of medicinal chemistry.

[45]  Jun Du,et al.  MC37, a new mono‐carbonyl curcumin analog, induces G2/M cell cycle arrest and mitochondria‐mediated apoptosis in human colorectal cancer cells , 2017, European journal of pharmacology.

[46]  L. Cai,et al.  Curcumin derivative WZ35 efficiently suppresses colon cancer progression through inducing ROS production and ER stress-dependent apoptosis. , 2017, American journal of cancer research.

[47]  P. Varalakshmi,et al.  Synthesis of a Water‐Soluble Pyrazole Curcumin Derivative: In Vitro and In Vivo AGE Inhibitory Activity and Its Mechanism , 2017 .

[48]  Jayme L. Dahlin,et al.  The Essential Medicinal Chemistry of Curcumin , 2017, Journal of medicinal chemistry.

[49]  A. M. Al-Abd,et al.  Molecular Mimics of Classic P-Glycoprotein Inhibitors as Multidrug Resistance Suppressors and Their Synergistic Effect on Paclitaxel , 2017, PloS one.

[50]  Fengli Xu,et al.  Development of resveratrol-curcumin hybrids as potential therapeutic agents for inflammatory lung diseases. , 2017, European journal of medicinal chemistry.

[51]  A. Allegra,et al.  Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies , 2017, Cancer investigation.

[52]  C. Supuran,et al.  Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors , 2017, Journal of enzyme inhibition and medicinal chemistry.

[53]  M. Coumar,et al.  In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[54]  Huan-qiu Li,et al.  Discovery of novel curcumin derivatives targeting xanthine oxidase and urate transporter 1 as anti-hyperuricemic agents. , 2017, Bioorganic & medicinal chemistry.

[55]  Yue Ma,et al.  Synthesis and biological evaluation of allylated mono-carbonyl analogues of curcumin (MACs) as anti-cancer agents for cholangiocarcinoma. , 2016, Bioorganic & medicinal chemistry letters.

[56]  J. Van Camp,et al.  Synthesis of novel curcuminoids accommodating a central β-enaminone motif and their impact on cell growth and oxidative stress. , 2016, European journal of medicinal chemistry.

[57]  Meng Zhang,et al.  Isothiouronium modification empowers pyrimidine-substituted curcumin analogs potent cytotoxicity and Golgi localization. , 2016, European journal of medicinal chemistry.

[58]  V. Khrustalev,et al.  1,5-Diaryl-3-oxo-1,4-pentadienes based on (4-oxopiperidin-1-yl)(aryl)methyl phosphonate scaffold: synthesis and antitumor properties , 2016, Medicinal Chemistry Research.

[59]  Gabriela L. Borosky,et al.  Fluoro-curcuminoids and curcuminoid-BF2 adducts: Synthesis, X-ray structures, bioassay, and computational/docking study , 2016 .

[60]  H. Sugimoto,et al.  Design and synthesis of curcumin derivatives as tau and amyloid β dual aggregation inhibitors. , 2016, Bioorganic & medicinal chemistry letters.

[61]  P. Sahu.  Design, structure activity relationship, cytotoxicity and evaluation of antioxidant activity of curcumin derivatives/analogues. , 2016, European journal of medicinal chemistry.

[62]  Bin Zhou,et al.  Synthesis and optimization of novel allylated mono-carbonyl analogs of curcumin (MACs) act as potent anti-inflammatory agents against LPS-induced acute lung injury (ALI) in rats. , 2016, European journal of medicinal chemistry.

[63]  Shilong Zheng,et al.  Design, synthesis, and biological evaluation of 1,9-diheteroarylnona-1,3,6,8-tetraen-5-ones as a new class of anti-prostate cancer agents. , 2016, Bioorganic & medicinal chemistry.

[64]  R. Konwar,et al.  Synthesis and biological evaluation of some novel triazole hybrids of curcumin mimics and their selective anticancer activity against breast and prostate cancer cell lines. , 2016, Bioorganic & medicinal chemistry letters.

[65]  A. Shafiee,et al.  Design and Synthesis of Curcumin-Like Diarylpentanoid Analogues as Potential Anticancer Agents. , 2016, Recent patents on anti-cancer drug discovery.

[66]  K. Rangappa,et al.  Synthesis and antiproliferative studies of curcumin pyrazole derivatives , 2016, Medicinal Chemistry Research.

[67]  S. Gupta,et al.  Synthesis and pharmacological activity evaluation of curcumin derivatives , 2016 .

[68]  A. Saxena,et al.  Triazole tethered C5-curcuminoid-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies. , 2016, European journal of medicinal chemistry.

[69]  F. Abas,et al.  Synthesis of unsymmetrical monocarbonyl curcumin analogues with potent inhibition on prostaglandin E2 production in LPS-induced murine and human macrophages cell lines. , 2016, Bioorganic & medicinal chemistry letters.

[70]  V. Shanmugaiah,et al.  Biological evaluation and molecular docking studies of new curcuminoid derivatives: Synthesis and characterization. , 2016, Bioorganic & medicinal chemistry letters.

[71]  Shilong Zheng,et al.  Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents. , 2016, European journal of medicinal chemistry.

[72]  M. Ramirez-Tortosa,et al.  Curcumin and Health , 2016, Molecules.

[73]  P. Sahu,et al.  Structure activity relationship, cytotoxicity and evaluation of antioxidant activity of curcumin derivatives. , 2016, Bioorganic & medicinal chemistry letters.

[74]  A. Minassi,et al.  Triazole-curcuminoids: A new class of derivatives for 'tuning' curcumin bioactivities? , 2016, Bioorganic & medicinal chemistry.

[75]  Jyoti.  Curcuminoid-derived 3,5-bis (styryl isoxazoles - Mechanochemical synthesis and antioxidant activity , 2016 .

[76]  E. Sousa,et al.  Curcumin: A Natural Lead for Potential New Drug Candidates. , 2015, Current medicinal chemistry.

[77]  A. Saxena,et al.  Triazole linked mono carbonyl curcumin-isatin bifunctional hybrids as novel anti tubulin agents: Design, synthesis, biological evaluation and molecular modeling studies. , 2015, Bioorganic & medicinal chemistry.

[78]  J. Ji,et al.  Design, synthesis, and anticancer evaluation of long-chain alkoxylated mono-carbonyl analogues of curcumin. , 2015, European journal of medicinal chemistry.

[79]  Nithya Subrahmanyam,et al.  A new class of hybrid anticancer agents inspired by the synergistic effects of curcumin and genistein: Design, synthesis, and anti-proliferative evaluation. , 2015, Bioorganic & medicinal chemistry letters.

[80]  V. Padmini,et al.  Synthesis and biological evaluation of new symmetric curcumin derivatives. , 2015, Bioorganic & medicinal chemistry letters.

[81]  H. Sakagami,et al.  Synthesis and Cytotoxic Activities of a Curcumin Analogue and Its bis- Mannich Derivatives , 2015 .

[82]  G. Venkatraman,et al.  Synthesis and anticancer activity of novel curcumin-quinolone hybrids. , 2015, Bioorganic & medicinal chemistry letters.

[83]  R. Araya-Maturana,et al.  Heterocyclic Curcumin Derivatives of Pharmacological Interest: Recent Progress. , 2015, Current topics in medicinal chemistry.

[84]  Hyoung-Gon Lee,et al.  Curcumin/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP/PS1 mouse model. , 2015, ACS chemical neuroscience.

[85]  F. Abas,et al.  Nitric oxide inhibitory activity and antioxidant evaluations of 2-benzoyl-6-benzylidenecyclohexanone analogs, a novel series of curcuminoid and diarylpentanoid derivatives. , 2015, Bioorganic & medicinal chemistry letters.

[86]  H. Shibata,et al.  Structure-Activity Relationships of the Antitumor C5-Curcuminoid GO-Y030 , 2015, Molecules.

[87]  Shilong Zheng,et al.  Structure-Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer Agents. , 2015, Journal of medicinal chemistry.

[88]  M. Rai,et al.  Curcumin nanoparticles: physico-chemical fabrication and its in vitro efficacy against human pathogens , 2015, 3 Biotech.

[89]  Qiaoxian Huang,et al.  Synthesis and assessment of the antioxidant and antitumor properties of asymmetric curcumin analogues. , 2015, European journal of medicinal chemistry.

[90]  D. Yanagisawa,et al.  Curcumin derivative with the substitution at C-4 position, but not curcumin, is effective against amyloid pathology in APP/PS1 mice , 2015, Neurobiology of Aging.

[91]  K. Priyadarsini.  The Chemistry of Curcumin: From Extraction to Therapeutic Agent , 2014, Molecules.

[92]  M. Diederich,et al.  Hybrid Curcumin Compounds: A New Strategy for Cancer Treatment , 2014, Molecules.

[93]  L. Xue,et al.  Therapeutic Effects of Curcumin on Alzheimer's Disease , 2014 .

[94]  A. Witkowska,et al.  Potential Application of Curcumin and Its Analogues in the Treatment Strategy of Patients with Primary Epithelial Ovarian Cancer , 2014, International journal of molecular sciences.

[95]  B. Aggarwal,et al.  Curcumin, a component of golden spice: from bedside to bench and back. , 2014, Biotechnology advances.

[96]  F. Abas,et al.  Synthesis and Sar Study of Diarylpentanoid Analogues as New Anti-Inflammatory Agents , 2014, Molecules.

[97]  G. Bifulco,et al.  Pharmacological evaluation and docking studies of α,β-unsaturated carbonyl based synthetic compounds as inhibitors of secretory phospholipase A₂, cyclooxygenases, lipoxygenase and proinflammatory cytokines. , 2014, Bioorganic & medicinal chemistry.

[98]  S. Toldo,et al.  Discovery of 5-(4-hydroxyphenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide as a neuroprotectant for Alzheimer's disease by hybridization of curcumin and melatonin. , 2014, ACS chemical neuroscience.

[99]  P. Zou,et al.  Synthesis and biological evaluation of allylated and prenylated mono-carbonyl analogs of curcumin as anti-inflammatory agents. , 2014, European journal of medicinal chemistry.

[100]  Chengguang Zhao,et al.  Discovery and identification of new non-ATP competitive FGFR1 inhibitors with therapeutic potential on non-small-cell lung cancer. , 2014, Cancer letters.

[101]  S. Rohani,et al.  Curcumin, a promising anti-cancer therapeutic: a review of its chemical properties, bioactivity and approaches to cancer cell delivery , 2014 .

[102]  S. Nabavi,et al.  Curcumin and Liver Disease: from Chemistry to Medicine. , 2014, Comprehensive reviews in food science and food safety.

[103]  S. I. Khalivulla,et al.  Anti-hyperalgesic effect of a benzilidine-cyclohexanone analogue on a mouse model of chronic constriction injury-induced neuropathic pain: Participation of the κ-opioid receptor and KATP , 2013, Pharmacology Biochemistry and Behavior.

[104]  Peiju Qiu,et al.  Exploring pyrimidine-substituted curcumin analogues: design, synthesis and effects on EGFR signaling. , 2013, Bioorganic & medicinal chemistry.

[105]  H. Fu,et al.  Design and biological characterization of hybrid compounds of curcumin and thalidomide for multiple myeloma. , 2013, Organic & biomolecular chemistry.

[106]  S. Gupta,et al.  Biological activity, design, synthesis and structure activity relationship of some novel derivatives of curcumin containing sulfonamides. , 2013, European journal of medicinal chemistry.

[107]  Jun Du,et al.  Deubiquitinase Inhibition of 19S Regulatory Particles by 4-Arylidene Curcumin Analog AC17 Causes NF-κB Inhibition and p53 Reactivation in Human Lung Cancer Cells , 2013, Molecular Cancer Therapeutics.

[108]  A. Noorafshan,et al.  A review of therapeutic effects of curcumin. , 2013, Current pharmaceutical design.

[109]  S. Gou,et al.  Design and synthesis of dimethylaminomethyl-substituted curcumin derivatives/analogues: potent antitumor and antioxidant activity, improved stability and aqueous solubility compared with curcumin. , 2013, Bioorganic & medicinal chemistry letters.

[110]  P. Jurutka,et al.  Synthesis and biological evaluation of halogenated curcumin analogs as potential nuclear receptor selective agonists. , 2013, Bioorganic & medicinal chemistry.

[111]  B. Aggarwal,et al.  Discovery of curcumin, a component of golden spice, and its miraculous biological activities , 2012, Clinical and experimental pharmacology & physiology.

[112]  B. Aggarwal,et al.  Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. , 2008, Biochemical pharmacology.

[113]  Robert A Newman,et al.  Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.

[114]  K. N. Babu,et al.  Turmeric: The genus Curcuma , 2007 .